Boundless Bio Announces Pricing of Initial Public Offering
SAN DIEGO–(BUSINESS WIRE)–Boundless Bio, Inc. (Nasdaq: BOLD), a clinical stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative…
Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO–(BUSINESS WIRE)–Boundless Bio, Inc. (Nasdaq: BOLD), a clinical stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative…
FRIENDSWOOD, Texas–(BUSINESS WIRE)–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced…
Special Meeting of Stockholders to Approve Plan of Dissolution Scheduled for Friday, May 10, 2024 at 10:00 a.m. Eastern Standard…
PARIS–(BUSINESS WIRE)–Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and…
Financial highlights €18.7 million available cash as of December 31st, 2023, not including the upcoming $48 million payment as part…
DUBLIN–(BUSINESS WIRE)–The “Synthetic Hormones Market – A Global and Regional Analysis: Focus on Product Type, Route of Administration, Application, End…
ISELIN, N.J.–(BUSINESS WIRE)–Ephicacy Consulting Group, Inc., (“Ephicacy”), a leading biometrics Contract Research Organization (“CRO”) and global provider of statistical programming,…
DUBLIN–(BUSINESS WIRE)–The “Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by…
Highlights include environmental goals based on climate science, workforce empowerment, focus on local partnerships, and supply chain resiliency. PHILADELPHIA–(BUSINESS WIRE)–PCI…
New funding from ARPA-H, in partnership with DARPA, directly supports development of next-generation technology for at-home treatment of rheumatoid arthritis…